Physician

Darren M. Lynch, MD

According to 2025 Medicare claims, Darren Lynch, MD (NPI: 1922087832) practices general practice in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is NORTHAMPTON INTEGRATIVE MEDICINE, LLC (NPI: 1134673882; TIN: 813511626) and primary practice location at 01060-3914. Lynch is affiliated with the UMASS Memorial Accountable Care Organization, INC. (ACO ID: A2598) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Lynch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 751 traditional Medicare patients, billed 17,994 HCPCS/CPT codes, and received $301,647 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,532 prescription claims across 245 beneficiaries totaling $151,805 in drug costs, led by Creon (Lipase/Protease/Amylase). DME data shows 358 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $131,970 to $301,647. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $190,918 and ending at $151,805. In contrast, DME billing represents a smaller volume and rose steadily, from $4,089 to $8,693.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$163K$325K2015 Medicare payment: $131,970 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $157,100 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $272,896 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $313,756 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $295,843 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $279,628 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $297,968 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $271,013 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $325,381 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $301,647 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201533711,507$131,970
201640314,655$157,100
201761122,093$272,896
201868725,291$313,756
201969121,778$295,843
202060017,670$279,628
202165214,603$297,968
202268314,277$271,013
202374018,810$325,381
202475117,994$301,647

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$184K$368K2015 Drug cost: $190,918 (USD; Tot_Drug_Cst)2016 Drug cost: $200,626 (USD; Tot_Drug_Cst)2017 Drug cost: $304,932 (USD; Tot_Drug_Cst)2018 Drug cost: $344,902 (USD; Tot_Drug_Cst)2019 Drug cost: $284,171 (USD; Tot_Drug_Cst)2020 Drug cost: $367,772 (USD; Tot_Drug_Cst)2021 Drug cost: $331,296 (USD; Tot_Drug_Cst)2022 Drug cost: $291,722 (USD; Tot_Drug_Cst)2023 Drug cost: $216,992 (USD; Tot_Drug_Cst)2024 Drug cost: $151,805 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151411,038$190,918
20161411,094$200,626
20171951,626$304,932
20182131,628$344,902
20192151,553$284,171
20202121,550$367,772
20211841,402$331,296
20222031,395$291,722
20232151,480$216,992
20242451,532$151,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$329K$658K2015 Medicare payment: $173,030 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $249,261 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $261,945 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $320,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $429,197 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $454,168 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $339,357 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $592,513 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $608,641 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $658,306 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R123$173,030
2016N/R215$249,261
2017N/R252$261,945
2018N/R294$320,857
2019N/R259$429,197
2020N/R266$454,168
2021N/R240$339,357
2022N/R357$592,513
202311389$608,641
2024N/R358$658,306

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more102102$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6851,791$90
82785Ige (immune system protein) level6970$16
95165Professional service for preparation and provision of 1 or more antigens463,535$11
86003Measurement of antibody (ige) to allergic substance, crude allergen extract, each796,539$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CreonLipase/Protease/Amylase12620$33,305
Cromolyn SodiumCromolyn Sodium481,396$13,750
AtovaquoneAtovaquone24647$11,269
Armour ThyroidThyroid,pork1008,010$10,736
TirosintLevothyroxine Sodium251,590$9,228

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R96$516,878
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mgNN/R42$123,248
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R30$9,889
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R92$6,327
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R98$1,963

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Darren M. Lynch, MD?

Tedicare shows public-source Medicare data for Darren M. Lynch, MD (NPI 1922087832), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Darren M. Lynch, MD have ACO affiliation data?

Darren M. Lynch, MD is shown with ACO affiliation data for UMASS Memorial Accountable Care Organization, INC. (MSSP, ACO ID A2598) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Darren M. Lynch, MD?

Darren M. Lynch, MD is linked to NORTHAMPTON INTEGRATIVE MEDICINE, LLC (billing NPI 1134673882) in the available physician profile data.

Does Darren M. Lynch, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.